185 related articles for article (PubMed ID: 11887820)
1. Peritonitis in automated peritoneal dialysis: antibiotic therapy and pharmacokinetics.
Diaz-Buxo JA; Crawford TL; Bailie GR
Perit Dial Int; 2001; 21 Suppl 3():S197-201. PubMed ID: 11887820
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.
Manley HJ; Bailie GR; Frye R; Hess LD; McGoldrick MD
J Am Soc Nephrol; 2000 Jul; 11(7):1310-1316. PubMed ID: 10864588
[TBL] [Abstract][Full Text] [Related]
3. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Intraperitoneal Cefalothin and Cefazolin in Patients Being Treated for Peritoneal Dialysis-Associated Peritonitis.
Roberts DM; Ranganathan D; Wallis SC; Varghese JM; Kark A; Lipman J; Roberts JA
Perit Dial Int; 2016; 36(4):415-20. PubMed ID: 26764340
[TBL] [Abstract][Full Text] [Related]
5. Initial treatment of CAPD peritonitis: poor response with association of cefazolin and amikacin.
Onozato ML; Caramori JC; Barretti P
Perit Dial Int; 1999; 19(1):88-9. PubMed ID: 10201353
[No Abstract] [Full Text] [Related]
6. Intermittent versus continuous antibiotics for PD-related peritonitis.
Golper T
Perit Dial Int; 1997; 17(1):11-2. PubMed ID: 9068015
[No Abstract] [Full Text] [Related]
7. Oral treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
Searle M; Raman GV
Clin Nephrol; 1985 May; 23(5):241-4. PubMed ID: 4006333
[TBL] [Abstract][Full Text] [Related]
8. Effective treatment of peritoneal dialysis-associated peritonitis with cefazolin and ceftazidime in children.
Rusthoven E; Monnens LA; Schröder CH
Perit Dial Int; 2001; 21(4):386-9. PubMed ID: 11587402
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of antibiotics used to treat peritoneal dialysis-associated peritonitis.
Johnson CA; Zimmerman SW; Rogge M
Am J Kidney Dis; 1984 Jul; 4(1):3-17. PubMed ID: 6377882
[TBL] [Abstract][Full Text] [Related]
10. A novel intraperitoneal cefepime regime based on pharmacokinetic modeling to treat CAPD peritonitis.
Yuen SK; Yuen YP; Fok SP; Yong SP; Tse MW; Chan AY
Perit Dial Int; 2010; 30(6):660-1. PubMed ID: 21148061
[No Abstract] [Full Text] [Related]
11. Outcomes of peritonitis in children on peritoneal dialysis: a 25-year experience at Severance Hospital.
Lee KO; Park SJ; Kim JH; Lee JS; Kim PK; Shin JI
Yonsei Med J; 2013 Jul; 54(4):983-9. PubMed ID: 23709435
[TBL] [Abstract][Full Text] [Related]
12. Correlation of intraperitoneal antibiotic pharmacokinetics and peritoneal membrane transport characteristics.
Elwell RJ; Bailie GR; Manley HJ
Perit Dial Int; 2000; 20(6):694-8. PubMed ID: 11216561
[TBL] [Abstract][Full Text] [Related]
13. Peritonitis and antibiotic therapy in patients on cycler peritoneal dialysis--an update.
Diaz-Buxo JA; Crawford TL
Adv Perit Dial; 2000; 16():229-32. PubMed ID: 11045300
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis.
Triyawatanyu P; Chariyavilaskul P; Phaisal W; Peerapornratana S; Kanjanabuch T; Praditpornsilpa K; Katavetin P
Perit Dial Int; 2020 Mar; 40(2):179-184. PubMed ID: 32063189
[TBL] [Abstract][Full Text] [Related]
15. Treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
Fenton P
J Antimicrob Chemother; 1984 May; 13(5):411-3. PubMed ID: 6735960
[No Abstract] [Full Text] [Related]
16. Lactococcus garvieae peritoneal dialysis peritonitis.
Chao CT; Lai CF; Huang JW
Perit Dial Int; 2013; 33(1):100-1. PubMed ID: 23349199
[No Abstract] [Full Text] [Related]
17. Intraperitoneal Cefepime Monotherapy Versus Combination Therapy of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-Associated Peritonitis: A Multicenter, Open-Label, Noninferiority, Randomized, Controlled Trial.
Kitrungphaiboon T; Puapatanakul P; Chuengsaman P; Tiskajornsiri K; Halue G; Siribamrungwong M; Matayart S; Chongthanakorn K; Poonvivatchaikarn U; Boonyakrai C; Somboonsilp W; Katavetin P; Praditpornsilpa K; Eiam-Ong S; Johnson DW; Kanjanabuch T
Am J Kidney Dis; 2019 Nov; 74(5):601-609. PubMed ID: 31331757
[TBL] [Abstract][Full Text] [Related]
18. Peritonitis in children undergoing continuous ambulatory peritoneal dialysis.
Powell D; Luis ES; Calvin S; McDaid T; Potter D
Am J Dis Child; 1985 Jan; 139(1):29-32. PubMed ID: 3969978
[TBL] [Abstract][Full Text] [Related]
19. Effects of intraperitoneal cefazolin on mesothelial cells in noninfected CAPD patients.
Manley HJ; Bailie GR
Perit Dial Int; 2001; 21(1):83-5. PubMed ID: 11280503
[No Abstract] [Full Text] [Related]
20. Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.
Peerapornratana S; Chariyavilaskul P; Kanjanabuch T; Praditpornsilpa K; Eiam-Ong S; Katavetin P
Perit Dial Int; 2017; 37(2):218-224. PubMed ID: 27738089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
